Decorin and lumican can suppress growth factor signaling (e.g., TGF-β and EGFR), while biglycan may promote inflammatory signaling through TLR2/4, underscoring their dual tumor-suppressive and tumor-promoting roles [63,64,65]. Here, DCN is linked to neoplasm.